Skip to main content
IONS
NASDAQ Life Sciences

Diranersen Slows Alzheimer's Decline Further at Two Years, 38% on CDR-SB

Tom Rudovsky · Reported by BusinessWire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$26.93
Mkt Cap
$4.49B
52W Low
$26.55
52W High
$86.74
52W Position info
1.4% above low
Off High info
69% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

IONS is trading near its 52-week low of $26.55 (1.4% above the low).

Summary

Partner Biogen presented two-year CELIA data at CTAD 2026 showing diranersen's benefit deepening over time in early Alzheimer's: the 60 mg twice-yearly arm slowed decline 38% on CDR-SB at Week 96 versus 26% at Week 76, and 54% on ADAS-Cog13 versus 42%. The drug was generally well tolerated with no new safety signals, and new 18-month biomarker data showed robust reductions in tau PET signal and plasma p-tau217. This is a Phase 2 asset that Biogen licensed worldwide in 2019 and that carries FDA Fast Track designation, so the readout supports advancing it toward Phase 3 rather than changing near-term revenue. It lands at a rough moment for the stock, which sits near its 52-week low after the November 9 guidance cut to about $100 million in 2026 TRYNGOLZA sales, so a pipeline win is a welcome offset but not a financial event. Watch for Biogen's Phase 3 design and start timing for diranersen.

At the time of this announcement, IONS was trading at $26.93 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.5B. The 52-week trading range was $26.55 to $86.74. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

IONS - Latest Insights

IONS
Nov 17, 2026, 3:03 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $28.02
Real-time Price: $26.99 info
Change: -$1.03 (-4%) info
Market Cap: $4.49B info
IONS
Nov 10, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $31.17
Real-time Price: $26.99 info
Change: -$4.18 (-13%) info
Market Cap: $4.49B info
IONS
Nov 09, 2026, 11:01 AM EST
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $28.67
Real-time Price: $26.99 info
Change: -$1.68 (-6%) info
Market Cap: $4.49B info
IONS
Nov 09, 2026, 8:33 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $31.50
Real-time Price: $26.99 info
Change: -$4.51 (-14%) info
Market Cap: $4.49B info
IONS
Nov 09, 2026, 7:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $37.00
Real-time Price: $26.99 info
Change: -$10.01 (-27%) info
Market Cap: $4.49B info